Loading...

Linical Co., Ltd.

2183.TJPX
Healthcare
Biotechnology
¥336.00
¥5.00(1.51%)

Linical Co., Ltd. (2183.T) Stock Competitors & Peer Comparison

See (2183.T) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
2183.T¥336.00+1.51%7.6B-14.12-¥23.87+4.75%
4587.T¥1,686.00+0.87%215.6B14.62¥114.16N/A
4592.T¥2,495.00+5.72%168.2B-38.20-¥61.12N/A
2160.T¥2,921.00+4.62%143.6B-158.93-¥17.87N/A
4974.T¥916.00+0.22%109.1B104.38¥8.68+1.88%
4565.T¥942.00+2.06%83.3B-35.89-¥25.66N/A
4593.T¥645.00+1.26%68.1B-13.66-¥45.55N/A
4894.T¥6,140.00-0.16%50.1B-75.71-¥80.57N/A
4889.T¥2,785.00-6.42%36.9B325.08¥8.93N/A
4563.T¥71.00-4.05%26.1B-0.65-¥114.38N/A
Showing 1 to 10 of 45 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

2183.T vs 4587.T Comparison August 2025

2183.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2183.T stands at 7.6B. In comparison, 4587.T has a market cap of 215.6B. Regarding current trading prices, 2183.T is priced at ¥336.00, while 4587.T trades at ¥1,686.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2183.T currently has a P/E ratio of -14.12, whereas 4587.T's P/E ratio is 14.62. In terms of profitability, 2183.T's ROE is -0.07%, compared to 4587.T's ROE of +0.26%. Regarding short-term risk, 2183.T is less volatile compared to 4587.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2183.T.Check 4587.T's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;